Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report. (Q54102813)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

title

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

author name string

M Koutsilieris

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

M Tzanela

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

T Dimopoulos

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

publication date

1 March 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

published in

The Prostate

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

volume

38

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

page(s)

313-316

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

cites work

Mechanisms of antineoplastic action of somatostatin analogs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990301%2938%3A4%3C313%3A%3AAID-PROS7%3E3.0.CO%3B2-8

retrieved

21 January 2018

Identifiers

DOI

10.1002/(SICI)1097-0045(19990301)38:4<313::AID-PROS7>3.0.CO;2-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

PubMed publication ID

10075011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10075011

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10075011

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54102813&oldid=860933601"